News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.

Seattle one of the best cities for biking, report says
A 2023 report from the PeopleForBikes organization has ranked Seattle as the third most bikeable large U.S. city. Rankings were determined by accessibility to different

Seattle is one of the best metros for launching a career
Seattle ranked second in a new Bankrate study discussing the best locations in America for starting a career. The city also came in first for

Just-Evotec awarded DOD contract worth up to $74M
Seattle-based biologics company Just-Evotec has announced a new contract with the Department of Defense worth a potential $74 million. The collaboration aims to create monoclonal

Exton-based Immunome to merge with Seattle-based company to continue cancer care
Seattle biotech company MorphImmune is set to be acquired by Immunome, a biopharmaceutical firm based in Pennsylvania. As both organizations specialize in oncology, the move

Evergreen Bioscience cluster’s plans crystallize
Evergreen Bioscience Innovation chose a tentative location for its new headquarters in Spokane’s University District. The organization notes that this may change before plans are

Seattle ranks among top 10 park systems in the country
Nonprofit organization Trust for Public Land ranked Seattle’s public park system as the eighth-best in the country. The study ranked the park systems of America’s

News in NW
Washington’s life sciences continue to grow, with activity spurred by mergers and acquisitions. In fact, three of this year’s 10 largest biotech acquisitions nationwide have

Kineta to receive $5 million milestone payment from Merck
Seattle-based biotech company Kineta will receive $5 million from Merck after achieving a milestone in development efforts. Although Kineta is centered around oncology and cancer

New test might expand ability to find tumor cells in blood
A professor at the University of Washington School of Medicine teamed up with Seattle biotech company RareCyte, Inc. to create a blood test that measures

Alzheimer’s and Parkinson’s biotech AltPep raises $52.9M Series B
Seattle-based biotech company AltPep has raised $52.9 million in a Series B round. The funding follows previous investments of $44.4 million in 2022 and $23

Teachers get a chance to learn in labs
Seattle-based Fred Hutchinson Cancer Center will extend its education offerings to eastern Washington this summer during a three-week STEM program for teachers. The announcement follows

City OKs design for Vulcan life science proposal in South Lake Union
Vulcan Inc., a Seattle-based development and real estate company, will move forward with the construction of a lab research facility after receiving approval from a
